Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study
NCT05117957
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER_GOV
Sponsor class
Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG:
Sorafenib
Sponsor
Bo Hyun Kim